{
    "clinical_study": {
        "@rank": "18124", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D 4000 IU", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Vitamin D 600 IU", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "African-Americans have higher rates of cardiovascular disease morbidity and mortality, as\n      well as vitamin D deficiency. Multiple observational studies have demonstrated an increased\n      risk of vitamin D deficiency in African Americans with type 2 diabetes and correlation\n      between cardiovascular disease and vitamin D levels; however, there is a lack of\n      interventional trials exploring this connection. The objective of this proposal is to\n      address the hypothesis that treatment of vitamin D deficiency in African Americans with type\n      2 diabetes will improve subclinical markers of cardiovascular disease."
        }, 
        "brief_title": "Vitamin D, Cardiovascular Disease, and African Americans", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Vitamin D Deficiency", 
            "Type 2 Diabetes Mellitus", 
            "Cardiovascular Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Vitamin D Deficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will be a double blinded, randomized controlled trial of vitamin D3\n      supplementation, 4,000 international units per day versus 600 international units per day,\n      for one year to determine the effects on markers of subclinical cardiovascular disease in\n      African Americans with type 2 diabetes and vitamin D deficiency. Outcome assessment will\n      focus on changes in carotid intima-medial thickness (CIMT - ultrasound of the thickness of\n      blood vessels in the neck), as well as markers of systemic inflammation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  African Americans of both genders\n\n          -  Age 50-70 years\n\n          -  Type 2 diabetes (A1C < 9.0%), on stable therapy with oral medications, insulin, or a\n             combination\n\n          -  25(OH)D level < 20 ng/ml\n\n          -  BP < 140/90 mmHg; LDL < 140 mg/dl\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Cardiovascular disease\n\n          -  Stage 3 or worse chronic kidney disease\n\n          -  High urine or serum calcium or history of recurrent kidney stones\n\n          -  Unstable medical conditions or major systemic diseases such as malignancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01655810", 
            "org_study_id": "201102160"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitamin D 4000 IU", 
                "description": "Multivitamin containing cholecalciferol 4000 units orally daily", 
                "intervention_name": "Vitamin D3", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Cholecalciferol"
            }, 
            {
                "arm_group_label": "Vitamin D 600 IU", 
                "description": "Multivitamin containing cholecalciferol 600 units orally daily", 
                "intervention_name": "Vitamin D3", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Cholecalciferol"
            }, 
            {
                "arm_group_label": [
                    "Vitamin D 4000 IU", 
                    "Vitamin D 600 IU"
                ], 
                "description": "500 mg orally twice daily", 
                "intervention_name": "Calcium carbonate", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcium Carbonate", 
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 1, 2012", 
        "location": {
            "contact": {
                "email": "cbernal@dom.wustl.edu", 
                "last_name": "Carlos Bernal-Mizrachi, MD", 
                "phone": "314-362-0934"
            }, 
            "facility": {
                "address": {
                    "city": "Saint Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63110"
                }, 
                "name": "Washington University"
            }, 
            "investigator": {
                "last_name": "Carlos Bernal-Mizrachi, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Vitamin D and Early Markers of Cardiovascular Disease in African Americans", 
        "overall_contact": {
            "email": "cbernal@dom.wustl.edu", 
            "last_name": "Carlis Bernal-Mizrachi, MD", 
            "phone": "314-362-0934"
        }, 
        "overall_official": {
            "affiliation": "Washington University", 
            "last_name": "Carlos Bernal-Mizrachi, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in carotid intima-medial thickness", 
            "safety_issue": "No", 
            "time_frame": "0, 6, and 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01655810"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in systemic inflammatory markers", 
                "safety_issue": "No", 
                "time_frame": "0, 6, and 12 months"
            }, 
            {
                "measure": "Serum calcium", 
                "safety_issue": "Yes", 
                "time_frame": "0, 1, 3, 6, 9, and 12 months"
            }, 
            {
                "measure": "Urinary Calcium", 
                "safety_issue": "Yes", 
                "time_frame": "0, 1, 3, 6, 9, and 12 months"
            }
        ], 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "American Diabetes Association", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }
}